Cortexyme Inc.

NASDAQ: CRTX · Real-Time Price · USD
1.95
0.05 (2.63%)
At close: Aug 01, 2022, 6:00 AM

Cortexyme Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a
Operating Income
-16.26M -21.57M -89.94M -21.68M -21.78M -23.31M
Interest Income
145K 72K 620K 128K 160K 227K
Pretax Income
-16.85M -21.64M -89.94M -21.71M -21.75M -23.09M
Net Income
-16.56M -21.71M -89.94M -21.71M -21.75M -23.09M
Selling & General & Admin
9.06M 9.11M 29.52M 7.64M 7.06M 6.49M
Research & Development
7.2M 12.76M 60.8M 14.04M 14.72M 16.82M
Other Expenses
n/a n/a n/a n/a n/a n/a
Operating Expenses
16.26M 21.86M 90.32M 21.68M 21.78M 23.31M
Interest Expense
590K 72K n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a
Cost & Expenses
16.26M 21.86M 90.32M 21.68M 21.78M 23.31M
Income Tax Expense
-284K 72K 146K -29K 29K 227K
Shares Outstanding (Basic)
32.47M 30.13M 29.77M 29.77M 29.59M 29.55M
Shares Outstanding (Diluted)
32.47M 30.13M 29.77M 29.77M 29.59M 29.55M
EPS (Basic)
-0.5 -0.72 -3.02 -0.73 -0.74 -0.78
EPS (Diluted)
-0.5 -0.72 -3.02 -0.73 -0.74 -0.78
EBITDA
-16.26M -21.86M -23.8M -21.62M -21.78M -23.31M
EBIT
-16.26M -21.57M n/a -21.68M -21.78M -23.31M
Depreciation & Amortization
86.06K 38K 84K 87K 87K 86K